14727
To delineate the effects of these motifs on the replicative capacity of HIV and to explore the possibility of extending the virus host range, known heterologous enhancer/promoters were inserted into the HIV-1 LTR in place of the NF-kappa B and Sp1 binding sites .
 DNA: HIV-1 LTR; DNA: Sp1 binding sites; DNA: heterologous enhancer/promoters; protein: NF-kappa B
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: cell line, protein, RNA, DNA, cell type 
Text: {0} 
 Entities: HIV-1 LTR, Sp1 binding sites, heterologous enhancer/promoters, NF-kappa B 
Answer:
 DNA: HIV-1 LTR; DNA: Sp1 binding sites; DNA: heterologous enhancer/promoters; protein: NF-kappa B